A new paper in Rheumatology Advances in Practice indicates that TikTok videos about gout are commonly misleading, inconsistent, or inaccurate. The paper is titled "Gout, TikTok and misleading information: A content analysis."
Dec 10, 2025
0
0
A new international study published in Osteoporosis International and led by Monash's Center for Medicine Use and Safety (CMUS) has investigated the risks of a second hip fracture, subsequent fractures, and death in people ...
Dec 8, 2025
0
0
Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the intensive chemotherapy often used, according to new research from Sylvester Comprehensive Cancer Center, ...
Dec 8, 2025
0
0
Giving adolescents living with HIV high-dose Vitamin D and calcium supplements can help improve their bone density and reduce the risk of fractures, a new study suggests.
Dec 12, 2025
0
0
On Dec. 5, the Committee on Immunization Practices voted to approve new recommendations delaying the child hepatitis B vaccine for infants, providing a win for the Make America Healthy Again movement while troubling many ...
Dec 8, 2025
0
0
McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks for some women later in life.
Dec 9, 2025
0
0
A major international survey of people receiving electroconvulsive therapy (ECT) has found that most patients are not asked about the childhood adversities or recent life stressors that they believe caused their difficulties.
Dec 10, 2025
0
0
Patients undergoing treatment for lymphoma often experience adverse side effects that can be so severe that they stop or slow treatment. But a new study shows that a virtual program focusing on diet and exercise is a feasible ...
Dec 7, 2025
0
0
It isn't just people—when given the chance, rats may also use cannabis to cope with stress, according to a study by researchers at Washington State University.
Dec 11, 2025
0
0
More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening ...
Dec 9, 2025
0
49
